VivAer Stylus and Console (IMAGE) Merryman Communications Caption A randomized controlled trial published in International Forum of Allergy and Rhinology confirms the safety and efficacy of VivAer&reg; for the treatment of nasal airway obstruction (NAO) caused by nasal valve collapse (NVC). VivAer, a non-invasive technology developed by Aerin Medical Inc., uses patented, temperature-controlled radiofrequency energy to provide long-term relief from nasal obstruction. Credit (C) Aerin Medical, Inc. Usage Restrictions Image should be used with appropriate caption and credit License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.